In this issue:
Efficacy of oral decitabine-cedazuridine
Integrating genomic features into CMML classification
TMLI plus high-dose etoposide and cyclophosphamide
Comparison between chemoimmunotherapy and GV, GIV and RV
Radiation for low-grade primary cutaneous B-cell lymphoma
Diagnostic utility of CSF biomarkers
5-year outcomes of R2
10-year efficacy of R2
Lenalidomide plus RAdR
Including PET parameters with clinical data to improve prediction of treatment failure
Obinutuzumab and PET-adapted ultra-low dose nodal radiotherapy
Please login below to download this issue (PDF)